je.st
news
Drug developer Virobay lines up $50M IPO
2014-09-11 08:15:58| Biotech - Topix.net
Drug developer Virobay Inc. hopes to raise $50 million in an initial public offering for a critical year of clinical trials, according to the Menlo Park company's U.S. Securities and Exchange Commission filing Wednesday. The offering is the latest in a line of Bay Area biotech IPOs, including ones that could hit the market yet this month.
Tags: lines
drug
developer
ipo
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||